Editors’ Note: We appreciate everyone who continues to share ideas and feedback! Email readers can reply to this email directly or anyone can email us at [email protected].
Or copy and paste this link to others: {{rp_refer_url}}

Three-in-one blend delivers 5g of creatine per serving, vegan collagen, and electrolytes.
🥸 Solving Creatine's Identity Crisis
For decades, creatine has been viewed as a giant tub of white powder on a shelf in GNC, purchased by men. The product worked. The science was airtight. And the market stayed small.
In 2024, the entire global creatine market was worth roughly $1.3 billion. Protein supplements, by comparison, hit $26 billion. Creatine is arguably the most evidence-backed supplement in existence, with over 1,000 human clinical trials, and yet it has been commercially underweight for years. The ratio of scientific credibility to market size has been absurdly out of balance.
That's changing now, and the mechanism isn't a new study or a new molecule. It's format and audience.
Two recent product launches tell the story cleanly: VitClear, a UK startup, released what it claims is the UK's first creatine soda. Unfabled, a women's wellness brand, launched a Creatine Superblend explicitly targeting female consumers who have never touched a shaker cup. Meanwhile, Create Wellness, the company that essentially invented the creatine gummy category, just closed a $20 million Series B at the end of March, led by Alliance Consumer Growth with participation from Unilever Ventures and Mike Repole's Impact Capital (the family office behind vitaminwater and BODYARMOR).
These are consumer brands using creatine as a platform ingredient, the way protein was used a decade ago.
The format unlock
Here's the structural problem creatine has had: it doesn't work well in the formats that mainstream consumers actually want.
Creatine monohydrate degrades into creatinine, which is a metabolically useless byproduct, when dissolved in water. Heat pasteurization and carbonation accelerate the breakdown. This is why roughly 80% of creatine products sold today are ready-to-mix powders. Powder is the most bioavailable, most cost-effective, and most proven format. It also requires you to own a shaker bottle, measure a scoop, tolerate a gritty texture, and commit to a ritual that feels distinctly gym-adjacent. For the traditional creatine consumer, that's fine. For 90% of the population, it's a non-starter.
The gummy started to change this. Searches for creatine gummies increased over 1,300% according to The Vitamin Shoppe's 2025 trend report. North America saw a 59% increase in new creatine gummy products between January 2025 and January 2026. Europe saw 48% brand growth in the same period. Create Wellness, the category's breakout brand, has now sold over 250 million gummies and is rolling into Target stores nationwide as of April 2026.
The main issue with gummies is that they cost roughly 3x more per gram of creatine than powder, and there's been a well-documented underdosing scandal. Independent testing has revealed that many gummy brands were delivering far less creatine than their labels promised. Create's products are now NSF Certified for Sport and third-party tested by Eurofins. The transparency pressure strengthened the market's credibility with mainstream consumers.
What comes next?
VitClear's creatine soda represents an attempt to crack the liquid format problem, which has been the industry's white whale. Multiple ingredient suppliers, including Glanbia with its encapsulated CreaBev technology and TSI Group with OptiCreatine, are racing to stabilize creatine in RTD (ready-to-drink) formats. If someone solves this at scale, it opens the door to the $50+ billion U.S. functional beverage market. What if creatine could be a featured ingredient in energy drinks, sport drinks, protein shakes?
Then there are the emerging formats: chews (VOW Nutrition and Momentous both launched creatine chews), stick packs, dissolvable strips, and hybrid products stacking creatine with collagen or electrolytes. Create Wellness announced alongside its Series B that it's launching a Creatine + Electrolytes product exclusively through Target, which is a format play that positions creatine as a hydration ingredient rather than a strength ingredient.
The format is not incidental to the strategy. The format is the strategy. Every new delivery mechanism is a bet on a different consumer occasion, a different shelf placement, and a different identity for the ingredient.
The women’s market is not a niche
The second transformation is who's buying.
SPINS data shows year-over-year creatine category growth of 120%, driven by an expanding consumer base that now includes women, Gen X, and older adults alongside traditional gym users.
TikTok is a huge catalyst. Interest in creatine among women has surged on the platform, with healthcare professionals reporting a wave of female patients asking about it based on what they've seen in their feeds. The content is coming from wellness creators talking about brain fog, energy during the luteal phase, and perimenopause symptoms.
Women have 70-80% lower endogenous creatine stores than men. They also consume 30-40% less dietary creatine on average, partly because creatine is found primarily in red meat and fish, and partly because women eat less of these foods. Their creatine synthesis rates are roughly 20% lower. All of this means women are starting from a lower baseline, so the relative benefit of topping off those stores through supplementation is potentially greater.
The research is especially compelling for perimenopause and menopause, where women face accelerated muscle loss, declining bone density, and cognitive changes driven by dropping estrogen levels. A 2026 randomized controlled trial in peri- and post-menopausal women found that creatine supplementation improved reaction time and increased frontal brain creatine levels by over 16%. Earlier research has linked each additional gram of dietary creatine above the population average to an 18% reduction in depression risk among female participants.
This is the scientific foundation that brands like Unfabled are building on. Their Creatine Superblend delivers 5g of creatine per serving alongside a vegan collagen builder and an electrolyte complex, explicitly positioned for women who want steady energy, clearer thinking, and whole-body strength. The formulation is a stack designed around the specific gaps in the female creatine research.
What protein’s trajectory tells us about creatine’s future
The analogy everyone in the creatine industry uses is protein, and it's the right one.
Protein went through exactly this arc. It started as a gym supplement, marketed towards bodybuilders. Then it got reformatted into bars, shakes, and RTDs. Then it got repositioned from "muscle building" to "satiety" and "healthy aging." Then it became a front-of-pack claim on yogurt, pasta, cereal, and snack foods. The ingredient didn't change. The audience, the format, and the narrative did. Today, protein is a $26 billion market and growing.
Creatine is following that trajectory roughly a decade behind. The science is arguably stronger (creatine's evidence base for cognitive function, women's health, and aging is expanding faster than protein's ever did in those categories). The format innovation is accelerating (gummies, sodas, chews, stick packs, functional beverages). The audience is diversifying (women, Gen X, older adults, GLP-1 users). And the institutional capital is arriving: Unilever Ventures, vitaminwater's founder, Alliance Consumer Growth investing in a creatine gummy company tells you where the market thinks this category is headed.
Why you should care
The brands that win won't be the ones with the best clinical data because the clinical data is already settled, and it's available to everyone. The winners will be the ones who figured out that the real product isn't creatine. It's the daily habit of taking creatine, made invisible enough to stick.
That's a format question, not a science question.
🔄 Read More
Stay Stacked,
The Stack
Follow us on X/Twitter: @StackedHealth_
Join our Discord
Or copy and paste this link to others: {{rp_refer_url}}
Current Referral Count: {{rp_num_referrals}}
What did you think of today's newsletter?
Disclaimer: This content is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment. We aim to provide useful, evidence-informed insights. Your health is personal, and decisions should be made based on what works best for you.